Accueil › Lymphome › Caroline du Nord › Durham
Essais cliniques pour Lymphome à Durham, NC
17 études pour Lymphome recherchent des participants dans et autour de Durham (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma
Recrutement en coursPhase 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · à 10 mi
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Recrutement en coursPhase 2
- Duke University, Durham
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
Recrutement en coursPhase 1/2
- Duke University Medical Center, Durham
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Recrutement en coursPhase 1/2
- UNC School of Medicine, Division of Hematology, Chapel Hill · à 10 mi
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
Recrutement en cours
- Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill · à 10 mi
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Recrutement en coursPhase 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · à 10 mi
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Recrutement en coursPhase 3
- Duke Cancer Institute, Durham
DALY II USA/ MB-CART2019.1 for DLBCL
Recrutement en coursPhase 2
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Recrutement en coursPhase 1
- Duke University Medical Center, Durham
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
Recrutement en cours
- North Carolina Basnight Cancer Hospital, Chapel Hill · à 10 mi
Registry of Older Patients With Cancer
Recrutement en coursÉtude observationnelle
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · à 10 mi
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Recrutement en coursPhase 1/2
- Duke University Medical Center, Duke Cancer Center, Durham
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Recrutement en coursPhase 2
- University of North Carolina, Chapel Hill · à 10 mi
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
Recrutement en cours
- Duke Cancer Institute, Durham
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Recrutement en coursPhase 1
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · à 10 mi
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Recrutement en coursÉtude observationnelle
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · à 10 mi
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Recrutement en coursPhase 2
- Durham VA Medical Center, Durham, NC, Durham
Essais pour Lymphome dans d'autres villes
- Houston, TX34 études
- Boston, MA33 études
- New York City, NY33 études
- Washington, DC23 études
- Baldwin Park, CA21 études
- Chicago, IL20 études
- St. Louis, MO15 études
- Philadelphia, PA15 études
- Cleveland, OH14 études
- Edison, NJ12 études
- Atlanta, GA12 études
- Seattle, WA12 études
Autres études à Durham
- Cancer du sein63 études
- Cancer (tous types)58 études
- Cancer du poumon non à petites cellules39 études
- Myélome multiple37 études
- Cancer métastatique33 études
- Leucémie aiguë myéloïde33 études
- Cancer du poumon32 études
- Cancer de la prostate32 études
- Cancer colorectal28 études
- Leucémie lymphocytaire chronique27 études
- Cancer de l'ovaire27 études
- Insuffisance cardiaque26 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.